pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    ecallantide
    Kalbitor (ecallantide)
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Dyax Corp
  • Marketed
    econazole nitrate
    Ecoza (econazole nitrate)
    Tinea Pedis (Athlete Foot) Resilia Pharmaceuticals Inc
  • Phase 3
    ecopipam hydrochloride
    ecopipam hydrochloride
    Tourette Syndrome Emalex Biosciences Inc
  • Marketed
← prev
page 173 of 231
next →
131
Pain89
Neurology1
ecothiopate iodide
Phospholine Iodide (ecothiopate iodide [INN])
Accommodative Esotropia
Fera Pharmaceuticals LLC
  • Marketed
    eculizumab
    Soliris (eculizumab)
    Paroxysmal Nocturnal Hemoglobinuria Alexion Pharmaceuticals Inc
  • Marketed
    edaravone
    Radicava ORS (edaravone)
    Amyotrophic Lateral Sclerosis$SGIOF SHIONOGI & CO LTD
  • Marketed
    edetate calcium disodium
    Edetate Calcium Disodium
    Lead Poisoning Casper Pharma LLC
  • Preclinical
    edodekin alfa SR
    edodekin alfa
    Pancreatic Cancer TherapyX Inc
  • Marketed
    edoxaban tosylate
    Savaysa (edoxaban tosylate)
    Atrial Fibrillation Daiichi Sankyo Co Ltd
  • Phase 2
    efarindodekin alfa
    efarindodekin alfa[INN]
    Cervical Cancer$GILD GILEAD SCIENCES, INC.
  • Marketed
    efavirenz
    Efavirenz
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Camber Pharmaceuticals Inc
  • Marketed
    efbemalenograstim alfa LA
    Ryzneuta (efbemalenograstim alfa)
    Chemotherapy Induced Neutropenia Acrotech Biopharma Inc
  • Phase 2
    efdoralprin alfa
    efdoralprin alfa [INN]
    Alpha-1 Antitrypsin Deficiency (A1AD)$SNY Sanofi
  • pre_registration
    efgartigimod alfa
    Vyvgart (efgartigimod alfa)
    Myasthenia Gravis$ARGX ARGENX SE
  • Phase 2
    efgitasialase alfa
    efgitasialase alfa
    Breast Cancer Palleon Pharmaceuticals Inc
  • Phase 2
    efineptakin alfa
    efineptakin alfa
    Radiation Toxicity (Radiation Sickness, Acute Radiation S… NeoImmuneTech Inc
  • Phase 2
    efinopegdutide
    efinopegdutide
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or…$MRK Merck & Co., Inc.
  • Marketed
    eflapegrastim
    Rolvedon (eflapegrastim-xnst)
    Chemotherapy Induced Neutropenia Spectrum Pharmaceuticals Inc
  • Phase 3
    eflornithine
    eflornithine [INN]
    Anaplastic Astrocytoma Orbus Therapeutics Inc
  • Phase 3
    efmirenpase alfa
    efmirenpase alfa [INN]
    Arterial Calcification$BMRN BIOMARIN PHARMACEUTICAL INC
  • Phase 2
    efocipegtrutide
    efocipegtrutide [INN]
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Hanmi Pharmaceuticals Co Ltd
  • Phase 2
    efpegerglucagon
    efpegerglucagon [INN]
    Hyperinsulinemia Hanmi Pharmaceuticals Co Ltd
  • Phase 3
    efruxifermin
    efruxifermin
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Akero Therapeutics Inc
  • Phase 3
    efsudenermin alfa
    efsudenermin alfa
    X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) EspeRare Foundation
  • Phase 3
    eftilagimod alfa
    eftilagimod alfa [INN]
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$IMMP IMMUTEP Ltd
  • Phase 3
    efzimfotase alfa
    efzimfotase alfa
    Hypophosphatasia Alexion Pharmaceuticals Inc
  • Phase 2
    efzofitimod
    efzofitimod [INN]
    Interstitial Lung Diseases (Diffuse Parenchymal Lung Dise…$ATYR aTYR PHARMA INC
  • Phase 2
    egalognastat
    egalognastat [INN]
    Progressive Supranuclear Palsy Grupo Ferrer Internacional SA
  • Marketed
    elacestrant hydrochloride
    Orserdu (elacestrant hydrochloride)
    Metastatic Breast Cancer A. Menarini Industrie Farmaceutiche Riunite Srl
  • Marketed
    eladocagene exuparvovec
    Kebilidi (eladocagene exuparvovec)
    Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency$PTC PTC INC.